MyAverix Finance
F · Healthcare
PHARMARON BEIJING H YC1 (17Q1)
Biotechnology
PHARMARON BEIJING H YC1 (17Q1) is listed on F in the Healthcare sector. Industry: Biotechnology. As of 2026-05-24, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 17Q1
PHARMARON BEIJING H YC1 (17Q1) — FAQ
What is 17Q1's P/E ratio?
The price-to-earnings (P/E) ratio for PHARMARON BEIJING H YC1 (17Q1) is 25.00 (data as of 2026-05-24).
Does PHARMARON BEIJING H YC1 pay a dividend?
Dividend yield is not available in the current snapshot for PHARMARON BEIJING H YC1 (17Q1). Check the MyAverix Finance app for the latest dividend data.
What sector is PHARMARON BEIJING H YC1 in?
PHARMARON BEIJING H YC1 (17Q1) is classified in the Healthcare sector (Biotechnology industry).
What exchange is 17Q1 listed on?
17Q1 is listed on F.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.